Title |
Clindamicina como terapia adyuvante en el sndrome de piel escaldada estafiloccica
|
---|---|
Published in |
Anales del Sistema Sanitario de Navarra, December 2014
|
DOI | 10.4321/s1137-66272014000300017 |
Pubmed ID | |
Authors |
F.J. Gil Senz, M. Herranz Aguirre, G. Durn Urdniz, L. Zandueta Pascual, J. Gimeno Ballester, E. Bernaola Iturbe |
Abstract |
Staphylococcal scalded skin syndrome (SSSS) is a dermatologic disease caused by exotoxins produced by Staphylococcus aureus. The disease presents as a painful cutaneous rash that culminates with the detachment of the superficial dermis. The usual treatment is antibiotics with beta-lactamase resistant penicillin. We report the case of a patient who presented with SSSS with initial torpid evolution despite antibiotic treatment and after the introduction of clindamycin IV experienced a very significant improvement. Concerns about the increase of methicillin resistant Staphylococcus aureus (MRSA) and the pathophysiology of this disease make bacteriostatic spectrum antistaphylococcal antibiotics, such as clindamycin, strong candidates for consideration as a first-line therapeutic arsenal for the treatment of SSSS. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 27% |
Student > Bachelor | 3 | 20% |
Other | 1 | 7% |
Student > Doctoral Student | 1 | 7% |
Researcher | 1 | 7% |
Other | 1 | 7% |
Unknown | 4 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 40% |
Nursing and Health Professions | 2 | 13% |
Agricultural and Biological Sciences | 1 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
Unknown | 5 | 33% |